Work

Abstract B099: BTK-EndoMut Platform: Engineered Resistance Models Accelerating BTK-Targeted Drug Discovery

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b099

Authors: Jinying B. Ning, feng B. hao, yue B. huang, Thomas A. Strong

Institutions: Ginkgo Bioworks, Inc. (United States), CanSino (China)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444510

Cites:

Cited by:

Related to: